France bleu21d
Addiction aux jeux et au sexe : la descente aux enfers des victimes de médicaments contre la maladie de Parkinson
Cela signifie que dès 2006, GSK est au courant que des recherches sont menées pour découvrir si le Requip pourrait devenir une sorte de nouveau Viagra ... de voir le logo de GSK notamment ...
GSK price target raised to 1,500 GBp from 1,440 GBp at JPMorgan
JPMorgan raised the firm’s price target on GSK (GSK) to 1,500 GBp from 1,440 GBp and keeps an Underweight rating on the shares.Maximize Your ...
GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
GSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
FierceBiotech12d
GSK offers up to £50M to conduct cancer vaccine research with the University of Oxford
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.
Shropshire Star12d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
The University of Oxford and GSK are to work on a vaccine to target cells in the pre-cancerous stage (PA) Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to ...
GSK launches $2.5 billion buyback, lifts sales target after stellar Q4
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
Fortune24d
British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
The Independent11d
Cancer vaccine being created by UK scientists could stop disease up to 20 years early
Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...
Zonebourse28d
GSK attend l'examen de la FDA pour la présentation d'un nouveau vaccin contre le zona
(Alliance News) - GSK PLC a déclaré vendredi que la Food & Drug Administration des États-Unis avait accepté sa seringue de vaccin Shingrix pour examen. La société pharmaceutique et ...
Yahoo Finance26d
GSK Enters Agreement to Acquire IDRx, Inc.
January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...
FierceBiotech26d
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal cancer asset. “We really became impressed with what IDRx had achieved ...